Clover Health Investments Stock News

The health insurer's business doesn't look like it will be healing anytime soon.

Clover Health Investments Corp - Class A (CLOV) shares closed today at 1.0% above its 52 week low of $3.13, giving the company a market cap of $1B. The stock is currently down 15.1% year-to-date, down 80.3% over the past 12 months, and down 69.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 50.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1625.5% The company's stock price performance over the past 12 months lags the peer average by 768.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade. The post CLOV Stock Alert: 4 Things to Know as Clover Health Hits an A

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CTO Andrew Toy has a great tool in the Clover Assistant, which can cut the costs of treating chronic conditions among aging patients. But will he get a chance to deploy it? The post The Two Faces of Clover Health appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

CTO Andrew Toy has a great tool in the Clover Assistant, which can cut the costs of treating chronic conditions among aging patients. But will he get a chance to deploy it?

NASHVILLE, Tenn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli,

Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here.

Clover Health's market cap dropped 74% in 2021. Heading into 2022, CLOV stock is not the $2 billion market cap to buy.

Clover Health Investments, Corp. (NASDAQ:CLOV) with the stream of 2.69% also noticed, India Oracle Corporation (NYSE:ORCL) encountered a rapid change of -0.16% in the last hour of Thursdays trading session. The post Stock with sudden spurt in volumes: Clover Health Investments, Corp. (NASDAQ:CLOV), Oracle Corporation (NYSE:ORCL) appeared first on Stocks Equity .

2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year.

Clover Health has plunged 76% in 2021, and Virgin Galactic is down 36%, in a tough year for billionaire investor Chamath Palihapitiya''s SPAC mergers.

In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $4.09, marking a -0.24% move from the previous day.

Parallel Advisors LLC purchased a new position in Clover Health Investments, Corp. (NASDAQ:CLOV) in the third quarter, Holdings Channel reports. The fund purchased 40,085 shares of the company’s stock, valued at approximately $296,000. Other hedge funds and other institutional investors also recently bought and sold shares of the company. Jacobi Capital Management LLC purchased a […]